279 related articles for article (PubMed ID: 10208444)
1. Anti-bipolar therapy: mechanism of action of lithium.
Jope RS
Mol Psychiatry; 1999 Mar; 4(2):117-28. PubMed ID: 10208444
[TBL] [Abstract][Full Text] [Related]
2. Overview of the mechanism of action of lithium in the brain: fifty-year update.
Lenox RH; Hahn CG
J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of action of lithium: intracellular signaling pathways].
Zorrilla Zubilete M
Vertex; 2003; 14(51):45-52. PubMed ID: 12690409
[TBL] [Abstract][Full Text] [Related]
4. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
Won E; Kim YK
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
[TBL] [Abstract][Full Text] [Related]
5. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.
Soeiro-de-Souza MG; Dias VV; Figueira ML; Forlenza OV; Gattaz WF; Zarate CA; Machado-Vieira R
Acta Psychiatr Scand; 2012 Nov; 126(5):332-41. PubMed ID: 22676371
[TBL] [Abstract][Full Text] [Related]
6. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
7. Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.
Li X; Friedman AB; Zhu W; Wang L; Boswell S; May RS; Davis LL; Jope RS
Biol Psychiatry; 2007 Jan; 61(2):216-22. PubMed ID: 16806104
[TBL] [Abstract][Full Text] [Related]
8. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
Machado-Vieira R
J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
[TBL] [Abstract][Full Text] [Related]
9. Lithium and synaptic plasticity.
Salinas PC; Hall AC
Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3beta as a likely target for the action of lithium on circadian clocks.
Padiath QS; Paranjpe D; Jain S; Sharma VK
Chronobiol Int; 2004 Jan; 21(1):43-55. PubMed ID: 15129823
[TBL] [Abstract][Full Text] [Related]
11. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders.
Brunello N; Tascedda F
Int J Neuropsychopharmacol; 2003 Jun; 6(2):181-9. PubMed ID: 12890311
[TBL] [Abstract][Full Text] [Related]
12. Potential mechanisms of action of lithium in bipolar disorder. Current understanding.
Malhi GS; Tanious M; Das P; Coulston CM; Berk M
CNS Drugs; 2013 Feb; 27(2):135-53. PubMed ID: 23371914
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.
Lenox RH; Wang L
Mol Psychiatry; 2003 Feb; 8(2):135-44. PubMed ID: 12610644
[TBL] [Abstract][Full Text] [Related]
14. The Wnt signaling pathway in bipolar disorder.
Gould TD; Manji HK
Neuroscientist; 2002 Oct; 8(5):497-511. PubMed ID: 12374432
[TBL] [Abstract][Full Text] [Related]
15. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
16. [Current hypotheses on the mechanism of action of lithium].
Wolf MA
Can J Psychiatry; 1987 Mar; 32(2):105-11. PubMed ID: 2436737
[TBL] [Abstract][Full Text] [Related]
17. Cytoskeleton involvement in lithium-induced SH-SY5Y neuritogenesis and the role of glycogen synthase kinase 3β.
Nciri R; Boujbiha MA; Jbahi S; Allagui MS; Elfeki A; Vincent C; Croute F
Aging Clin Exp Res; 2015 Jun; 27(3):255-63. PubMed ID: 25409859
[TBL] [Abstract][Full Text] [Related]
18. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
Bauer M; Alda M; Priller J; Young LT;
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
[TBL] [Abstract][Full Text] [Related]
19. Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice.
Böer U; Cierny I; Krause D; Heinrich A; Lin H; Mayr G; Hiemke C; Knepel W
Neuropsychopharmacology; 2008 Sep; 33(10):2407-15. PubMed ID: 18046304
[TBL] [Abstract][Full Text] [Related]
20. Lithium-related genetics of bipolar disorder.
Detera-Wadleigh SD
Ann Med; 2001 May; 33(4):272-85. PubMed ID: 11405549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
